# Novel 99mTc-labeled Somatostatin Antaginosts in the Diagnostic Algotithm of Neuroendocrine Neoplasms

> **NCT05871320** · EARLY_PHASE1 · COMPLETED · sponsor: **Jagiellonian University** · enrollment: 10 (actual)

## Conditions studied

- Neuroendocrine Tumors

## Interventions

- **DRUG:** [99mTc]Tc-TECANT1

## Key facts

- **NCT ID:** NCT05871320
- **Lead sponsor:** Jagiellonian University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-23
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-06-30
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2023-09-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05871320

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05871320, "Novel 99mTc-labeled Somatostatin Antaginosts in the Diagnostic Algotithm of Neuroendocrine Neoplasms". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05871320. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*